KCL011
KCLe015-A
General
Cell Line |
|
| hPSCreg name | KCLe015-A |
| Cite as: | KCLe015-A (RRID:CVCL_A245) |
| Alternative name(s) |
KCL011
|
| Cell line type | Human embryonic stem cell (hESC) |
| Similar lines | No similar lines found. |
| Last update | 28th July 2017 |
| User feedback | |
Provider |
|
| Generator |
King's College London (KCL)
Contact:
Department of Women's Health |
| Derivation country | United Kingdom |
External Databases |
|
| Cellosaurus | CVCL_A245 |
| NIHhESC | NIHhESC-13-0212 |
| Wikidata | Q54899659 |
General Information |
|
| * Is the cell line readily obtainable for third parties? |
Yes |
Donor Information
General Donor Information |
|
| Sex | female |
Phenotype and Disease related information (Donor) |
|
| Diseases | |
Ethics
| Alternatives to consent are available? | Yes |
| Alternatives to consent | |
| Alternative consent approval number | NIHhESC-13-0212 |
hESC Derivation
| Date of derivation | 2009-06-11 |
| Embryo stage | Blastula with ICM and Trophoblast |
| Expansion status |
5
|
| ICM morphology |
C
|
| Trophectoderm morphology |
b
|
| ZP removal technique | Mechanical |
| Cell isolation | None |
| Cell seeding | Embryo |
Culture Conditions
| Surface coating | Cellstart | ||||||
| Feeder cells |
Human Foreskin Fibroblast Cellfinder Ont Id: CELDA_000001419 |
||||||
| O2 Concentration | 5 % | ||||||
| CO2 Concentration | 6 % | ||||||
| Medium |
Other medium:
Base medium: KOSR-XF
Main protein source: Knock-out serum replacement Serum concentration: 15 % Supplements
|
Characterisation
Analysis of Undifferentiated Cells
| Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
| Alkaline Phosphatase |
Yes |
|
||||
| NANOG |
Yes |
|
||||
| POU5F1 (OCT-4) |
Yes |
|
||||
| TRA 1-60 |
Yes |
|
||||
| TRA 1-81 |
Yes |
|
Genotyping
Karyotyping (Cell Line) |
|
| Has the cell line karyotype been analysed? |
Yes
46XX
Passage number: 7
|
Other Genotyping (Cell Line) |
|

Login to share your feedback, experiences or results with the research community.